JBIO – jade biosciences, inc. (US:NASDAQ)
Stock Stats
News
Jade Biosciences (JBIO) had its "buy" rating reaffirmed by HC Wainwright.
Jade Biosciences (JBIO) was upgraded by Weiss Ratings from "sell (d-)" to "sell (d)".
Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
Jade Biosciences: Caution Advised Before Clinical Trial Results [Seeking Alpha]
Form SCHEDULE 13G/A Jade Biosciences, Inc. Filed by: BlackRock, Inc.
Form 8-K Jade Biosciences, Inc. For: Apr 18
Form PRE 14A Jade Biosciences, Inc. For: Jun 09
Form 8-K Jade Biosciences, Inc. For: Mar 31
Form S-8 Jade Biosciences, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.